MedImmune used to be a great place to work, but it's acquisition by AstraZeneca changed all that - Recensione dipendente - Associate Director presso AstraZeneca

2,0
25 lug 2013
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great people. Dedicated to developing medicines to make patients' lives better

Svantaggi

Now saddled with massive AstraZeneca bureaucracy and resulting pharma-related continuous reorganizations and layoffs

Esplora altre recensioni su AstraZeneca

5,0
17 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

great place to work and develop!

Svantaggi

could maybe have more transparency

1,0
19 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

The page is friendly to make an application.

Svantaggi

As an experienced healthcare analytics and commercial leader, I applied to 104 U.S.-based positions at AstraZeneca between 2025 and 2026 that closely matched my background. Despite receiving interviews from peer organizations, I did not receive a single recruiter interaction. I fully understand the competitiveness of hiring, but such a complete lack of engagement raises questions about potential overreliance on AI screening or unintended bias.

Vedi recensioni per: Utile|Valutazione|Data|Tutto